{"id":"https://openalex.org/W2002632285","doi":"https://doi.org/10.4088/jcp.v63n0208","title":"Hepatotoxicity Associated With the New Antidepressants","display_name":"Hepatotoxicity Associated With the New Antidepressants","alternate_titles":[],"publication_year":2002,"publication_date":"2002-02-15","ids":{"openalex":"https://openalex.org/W2002632285","doi":"https://doi.org/10.4088/jcp.v63n0208","mag":"2002632285","pmid":"https://pubmed.ncbi.nlm.nih.gov/11874214"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.v63n0208","doi":"https://doi.org/10.4088/jcp.v63n0208","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v63n0208","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2002632285"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067280353","display_name":"Alfonso Carvajal Garc\u00eda\u2010Pando","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108103353","display_name":"Universidad de Valladolid","ror":"https://ror.org/01fvbaw18","country_code":"ES","type":"education","lineage":["https://openalex.org/I108103353"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alfonso Carvajal Garcia-Pando","raw_affiliation_strings":["Instituto de Farmacoepidemiolog\u00eda de la Universidad de Valladolid, Spain. carvajal@ife.uva.es"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Farmacoepidemiolog\u00eda de la Universidad de Valladolid, Spain. carvajal@ife.uva.es","institution_ids":["https://openalex.org/I108103353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023056196","display_name":"Javier Garc\u00eda del Pozo","orcid":"https://orcid.org/0000-0003-0361-1504","observed_orcids":["https://orcid.org/0000-0003-0361-1504"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Javier Garcia del Pozo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Ana Sanchez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ana Sanchez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112347388","display_name":"Alfonso Velasco Mart\u00edn","orcid":"https://orcid.org/0009-0005-4306-3399","observed_orcids":["https://orcid.org/0009-0005-4306-3399"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alfonso Velasco Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109185880","display_name":"Ana Mar\u00eda Rueda de Castro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ana Maria Rueda de Castro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5073880418","display_name":"M. Isabel Lucena","orcid":"https://orcid.org/0000-0001-9586-4896","observed_orcids":["https://orcid.org/0000-0001-9586-4896"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Isabel Lucena","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.9754,"has_fulltext":false,"cited_by_count":115,"citation_normalized_percentile":{"value":0.9730669,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"63","issue":"2","first_page":"135","last_page":"137"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.027000000700354576,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11635","display_name":"Poisoning and overdose treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.824999988079071},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9649999737739563},{"id":"https://openalex.org/keywords/drug-induced-liver-injury","display_name":"drug-induced liver injury","score":0.8870000243186951},{"id":"https://openalex.org/keywords/nefazodone","display_name":"nefazodone","score":0.8849999904632568},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":0.9660000205039978},{"id":"https://openalex.org/keywords/clomipramine","display_name":"clomipramine","score":1.0},{"id":"https://openalex.org/keywords/spontaneous-adverse-drug-reporting","display_name":"spontaneous adverse drug reporting","score":0.6349999904632568},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.9430000185966492},{"id":"https://openalex.org/keywords/incidence-estimation","display_name":"incidence estimation","score":0.7210000157356262},{"id":"https://openalex.org/keywords/drug-sales-data","display_name":"drug sales data","score":0.6539999842643738},{"id":"https://openalex.org/keywords/depression-treatment","display_name":"depression treatment","score":0.3619999885559082}],"concepts":[{"id":"https://openalex.org/C2779419675","wikidata":"https://www.wikidata.org/wiki/Q416632","display_name":"Nefazodone","level":5,"score":0.9634186029434204},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.7107745409011841},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.706062376499176},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.705852746963501},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.648766279220581},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6476049423217773},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6326104402542114},{"id":"https://openalex.org/C2779305415","wikidata":"https://www.wikidata.org/wiki/Q58713","display_name":"Clomipramine","level":2,"score":0.6057634949684143},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5728077292442322},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5697771310806274},{"id":"https://openalex.org/C88879693","wikidata":"https://www.wikidata.org/wiki/Q217690","display_name":"Cumulative incidence","level":3,"score":0.42617395520210266},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3977583944797516},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.35772067308425903},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.26063987612724304},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.09731543064117432},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008107","descriptor_name":"Liver Diseases","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D008107","descriptor_name":"Liver Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.v63n0208","doi":"https://doi.org/10.4088/jcp.v63n0208","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v63n0208","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:11874214","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11874214","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1997078856","https://openalex.org/W4396685530","https://openalex.org/W2811135974","https://openalex.org/W44455618","https://openalex.org/W2025716972","https://openalex.org/W1985469636","https://openalex.org/W2725128628","https://openalex.org/W2417190875","https://openalex.org/W2099415813","https://openalex.org/W2741507568"],"abstract_inverted_index":{"BACKGROUND:":[0],"Safety":[1],"profiles":[2],"of":[3,19,43,53,132,151,157,175],"classical":[4],"and":[5,60,153,171],"new":[6,26],"antidepressants":[7,27,95],"are":[8],"well":[9],"established.":[10],"Hepatotoxicity":[11],"is":[12,181],"known":[13],"to":[14,33,77,106,136,139,163],"occur.":[15],"Recently,":[16],"several":[17],"cases":[18,52,100,124],"severe":[20],"hepatic":[21,44,54,133],"injury":[22],"associated":[23,47],"with":[24,48,122],"the":[25,40,63,78,94,115,119,148,154,164,179],"have":[28,71],"been":[29],"reported,":[30],"prompting":[31],"us":[32],"quantify":[34],"this":[35],"risk.":[36],"METHOD:":[37],"To":[38],"estimate":[39],"cumulative":[41],"incidence":[42,87,121,131],"adverse":[45,134],"reactions":[46,135],"antidepressants,":[49,158],"we":[50,70],"used":[51,72],"damage":[55],"collected":[56],"via":[57],"spontaneous":[58],"reporting":[59],"included":[61],"in":[62],"Spanish":[64,79],"Pharmacovigilance":[65],"System":[66],"database;":[67],"for":[68,93,104,108,111],"exposure,":[69],"data":[73],"from":[74,98],"drug":[75],"sales":[76],"National":[80],"Health":[81],"System.":[82],"RESULTS:":[83],"The":[84,129],"estimated":[85,144],"reported":[86,130],"did":[88],"not":[89],"show":[90],"major":[91],"differences":[92],"studied,":[96],"ranging":[97],"1.28":[99],"per":[101,125],"100,000":[102,126],"patient-years":[103],"sertraline":[105],"4.00":[107],"clomipramine,":[109],"except":[110],"nefazodone,":[112],"which":[113],"was":[114],"agent":[116],"that":[117,143,166],"had":[118],"highest":[120],"28.96":[123],"patient-years.":[127],"CONCLUSION:":[128],"nefazodone":[137],"seems":[138],"be":[140,161],"higher":[141],"than":[142],"so":[145],"far.":[146],"Given":[147],"high":[149],"prevalence":[150],"depression":[152],"widespread":[155],"use":[156],"physicians":[159],"should":[160],"alert":[162],"possibility":[165],"these":[167],"medications":[168],"cause":[169],"hepatitis":[170],"consider":[172],"early":[173],"discontinuation":[174],"an":[176],"antidepressant":[177],"if":[178],"condition":[180],"suspected.":[182]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2002632285","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
